Guardian Investment Management Decreased General Electric Co (GE) Holding By $881,981, Weatherbie Capital Trimmed Puma Biotechnology Com (Call) (PBYI) Holding By $7.81 Million

June 19, 2017 - By Ellis Scott

Weatherbie Capital Llc decreased Puma Biotechnology Inc Com (Call) (PBYI) stake by 99.31% reported in 2016Q4 SEC filing. Weatherbie Capital Llc sold 260,486 shares as Puma Biotechnology Inc Com (Call) (PBYI)’s stock declined 6.09%. The Weatherbie Capital Llc holds 1,800 shares with $55,000 value, down from 262,286 last quarter. Puma Biotechnology Inc Com (Call) now has $2.89B valuation. The stock rose 1.22% or $0.95 reaching $78.85. About 114,618 shares traded. Puma Biotechnology Inc (NYSE:PBYI) has risen 23.65% since June 19, 2016 and is uptrending. It has outperformed by 6.95% the S&P500.

Guardian Investment Management decreased General Electric Co (GE) stake by 18.71% reported in 2016Q4 SEC filing. Guardian Investment Management sold 28,451 shares as General Electric Co (GE)’s stock declined 7.64%. The Guardian Investment Management holds 123,604 shares with $3.91M value, down from 152,055 last quarter. General Electric Co now has $251.83B valuation. The stock declined 0.21% or $0.06 reaching $28.94 per share. About 4.16 million shares traded. General Electric Company (NYSE:GE) has declined 4.46% since June 19, 2016 and is downtrending. It has underperformed by 21.16% the S&P500.

Among 8 analysts covering Puma Biotechnology Inc (NYSE:PBYI), 7 have Buy rating, 0 Sell and 1 Hold. Therefore 88% are positive. Puma Biotechnology Inc had 22 analyst reports since August 27, 2015 according to SRatingsIntel. The rating was maintained by Credit Suisse with “Outperform” on Thursday, September 22. RBC Capital Markets maintained the shares of PBYI in report on Thursday, May 25 with “Sector Perform” rating. The firm has “Outperform” rating given on Tuesday, March 29 by Credit Suisse. UBS maintained Puma Biotechnology Inc (NASDAQ:PBYI) on Monday, April 11 with “Buy” rating. As per Tuesday, May 23, the company rating was maintained by Stifel Nicolaus. On Tuesday, May 23 the stock rating was maintained by Cowen & Co with “Market Perform”. Cowen & Co upgraded the shares of PBYI in report on Thursday, May 25 to “Outperform” rating. The stock of Puma Biotechnology Inc (NASDAQ:PBYI) has “Outperform” rating given on Thursday, January 21 by Credit Suisse. JP Morgan maintained the shares of PBYI in report on Tuesday, March 29 with “Overweight” rating. The stock of Puma Biotechnology Inc (NASDAQ:PBYI) has “Sector Perform” rating given on Tuesday, March 29 by RBC Capital Markets.

Investors sentiment decreased to 1.32 in Q4 2016. Its down 0.17, from 1.49 in 2016Q3. It dived, as 36 investors sold PBYI shares while 21 reduced holdings. 22 funds opened positions while 53 raised stakes. 34.24 million shares or 16.48% more from 29.40 million shares in 2016Q3 were reported. Sivik Glob Healthcare Limited Liability Corporation owns 30,000 shares. Weatherbie Llc accumulated 253,802 shares or 0.98% of the stock. State Of New Jersey Common Pension Fund D holds 0% or 25,833 shares in its portfolio. Rhumbline Advisers has 0% invested in Puma Biotechnology Inc (NASDAQ:PBYI) for 32,033 shares. Jana Prtnrs Limited Liability Com holds 0.08% or 142,727 shares in its portfolio. New York-based Goldman Sachs Group Inc has invested 0% in Puma Biotechnology Inc (NASDAQ:PBYI). 875,718 were accumulated by Millennium Mngmt Ltd Llc. 11,278 were reported by Northern Capital Mgmt Limited Liability. Barclays Plc, a United Kingdom-based fund reported 5,509 shares. Cam Grp Holding A S reported 30,000 shares or 0.02% of all its holdings. Jpmorgan Chase And, New York-based fund reported 89,569 shares. Wells Fargo Mn, a California-based fund reported 21,950 shares. Credit Suisse Ag stated it has 0% in Puma Biotechnology Inc (NASDAQ:PBYI). Guggenheim Cap Limited Liability has invested 0.01% of its portfolio in Puma Biotechnology Inc (NASDAQ:PBYI). Morgan Stanley holds 522,096 shares or 0.01% of its portfolio.

Since January 20, 2017, it had 0 insider buys, and 9 selling transactions for $158.24 million activity. Lo Steven had sold 2,290 shares worth $76,108 on Friday, January 20. $76,208 worth of stock was sold by BRYCE RICHARD PAUL on Friday, January 20. ADAGE CAPITAL PARTNERS GP – L.L.C. also sold $44.54 million worth of Puma Biotechnology Inc (NASDAQ:PBYI) shares. CHARNAS ROBERT sold $95,755 worth of stock or 3,008 shares. The insider EYLER CHARLES R sold 820 shares worth $27,253. On Friday, January 20 the insider AUERBACH ALAN H sold $339,064.

Weatherbie Capital Llc increased Siteone Landscape Supply Inc stake by 125,028 shares to 403,793 valued at $14.02 million in 2016Q4. It also upped Stamps Com Inc Com New (NASDAQ:STMP) stake by 63,140 shares and now owns 369,298 shares. Acadia Pharmaceuticals Inc Com (NASDAQ:ACAD) was raised too.

Since January 23, 2017, it had 5 buys, and 1 insider sale for $1.20 million activity. On Tuesday, January 31 Bornstein Jeffrey S bought $148,150 worth of General Electric Company (NYSE:GE) or 5,000 shares. Shares for $110,800 were bought by Beattie William G. 100,000 shares were bought by IMMELT JEFFREY R, worth $2.81 million. DIMITRIEF ALEXANDER bought $7,046 worth of General Electric Company (NYSE:GE) on Monday, January 23. The insider Joyce David Leon sold $4.72M.

Analysts await General Electric Company (NYSE:GE) to report earnings on July, 21 before the open. They expect $0.26 EPS, down 49.02% or $0.25 from last year’s $0.51 per share. GE’s profit will be $2.26B for 27.83 P/E if the $0.26 EPS becomes a reality. After $0.21 actual EPS reported by General Electric Company for the previous quarter, Wall Street now forecasts 23.81% EPS growth.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our daily email newsletter.




Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: